FOXO TECHNOLOGIES INC. Debt and Equity Securities, Gain (Loss)
FOXO TECHNOLOGIES INC. (FOXO) reported Debt and Equity Securities, Gain (Loss) of $47.84 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Income Statement › Other Income
us-gaap:DebtAndEquitySecuritiesGainLoss · last filed 2025-11-10
- FOXO TECHNOLOGIES INC. debt and equity securities, gain (loss) for the quarter ending 2025-09-30 was -$352.16K.
- FOXO TECHNOLOGIES INC. debt and equity securities, gain (loss) for the quarter ending 2025-06-30 was -$400.00K.
- FOXO TECHNOLOGIES INC. debt and equity securities, gain (loss) for the quarter ending 2025-03-31 was $800.00K.
| Period end | Debt and Equity Securities, Gain (Loss) | Debt and Equity Securities, Gain (Loss) 3 month | Debt and Equity Securities, Gain (Loss) 6 month | Debt and Equity Securities, Gain (Loss) 9 month |
|---|---|---|---|---|
| 2025-09-30 | -$352.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$752.16K derived: sum of 2 quarters · filed 2025-11-10 | $47.84K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | $400.00K 10-Q · filed 2025-08-19 | ||
| 2025-03-31 | $800.00K 10-Q/A · filed 2025-08-19 | |||
| 2024-05-28 | $2.30M 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |